125 related articles for article (PubMed ID: 38530428)
1. Perfusion percentage signal recovery and a mundane chicken wire: what could they have to do in oligodendrogliomas?
Lui E
Eur Radiol; 2024 Mar; ():. PubMed ID: 38530428
[No Abstract] [Full Text] [Related]
2. Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery percentiles.
Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Martinez-Zalacain I; Castell J; Camins A; Vidal N; Bruna J; Cos M; Perez-Lopez R; Oleaga L; Warnert E; Smits M; Majos C
Eur Radiol; 2024 Jan; ():. PubMed ID: 38282078
[TBL] [Abstract][Full Text] [Related]
3. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807
[TBL] [Abstract][Full Text] [Related]
4. Infratentorial oligodendrogliomas: Imaging findings in six patients.
Lee IH; Kim ST; Suh YL; Kim HJ; Kim KH; Jeon P; Byun HS
Acta Radiol; 2010 Mar; 51(2):213-7. PubMed ID: 19912073
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Cha S; Lupo JM; Chen MH; Lamborn KR; McDermott MW; Berger MS; Nelson SJ; Dillon WP
AJNR Am J Neuroradiol; 2007; 28(6):1078-84. PubMed ID: 17569962
[TBL] [Abstract][Full Text] [Related]
6. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
7. Impact of Specific Crossing Techniques in Chronic Total Occlusion Percutaneous Coronary Intervention on Recovery of Absolute Myocardial Perfusion.
Schumacher SP; Stuijfzand WJ; Driessen RS; van Diemen PA; Bom MJ; Everaars H; Kockx M; Raijmakers PG; Boellaard R; van de Ven PM; van Rossum AC; Opolski MP; Nap A; Knaapen P
Circ Cardiovasc Interv; 2019 Nov; 12(11):e008064. PubMed ID: 31672032
[TBL] [Abstract][Full Text] [Related]
8. Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas.
Watanabe T; Yokoo H; Yokoo M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 2001 Dec; 60(12):1181-9. PubMed ID: 11764090
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging features of intracranial astrocytomas and oligodendrogliomas in dogs.
Young BD; Levine JM; Porter BF; Chen-Allen AV; Rossmeisl JH; Platt SR; Kent M; Fosgate GT; Schatzberg SJ
Vet Radiol Ultrasound; 2011; 52(2):132-41. PubMed ID: 21388463
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.
Bian W; Khayal IS; Lupo JM; McGue C; Vandenberg S; Lamborn KR; Chang SM; Cha S; Nelson SJ
Transl Oncol; 2009 Dec; 2(4):271-80. PubMed ID: 19956389
[TBL] [Abstract][Full Text] [Related]
11. Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire.
Kurita T; Sakuma H; Onishi K; Ishida M; Kitagawa K; Yamanaka T; Tanigawa T; Kitamura T; Takeda K; Ito M
Eur Heart J; 2009 Feb; 30(4):444-52. PubMed ID: 19098020
[TBL] [Abstract][Full Text] [Related]
12. Fluid-attenuated inversion-recovery MR imaging in assessment of intracranial oligodendrogliomas.
White ML; Zhang Y; Smoker WR; Kirby PA; Hayakawa M; Sickels WJ; Ryken TC; Berbaum K
Comput Med Imaging Graph; 2005 Jun; 29(4):279-85. PubMed ID: 15890255
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of oligodendroglial and astrocytic tumors using imaging results: the added value of perfusion MR imaging.
Yoon HJ; Ahn KJ; Lee S; Jang JH; Choi HS; Jung SL; Kim BS; Jeun SS; Hong YK
Neuroradiology; 2017 Jul; 59(7):665-675. PubMed ID: 28550465
[TBL] [Abstract][Full Text] [Related]
14. Homozygous deletions of the CDKN2C/p18INK4C gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas.
Pohl U; Cairncross JG; Louis DN
Brain Pathol; 1999 Oct; 9(4):639-43. PubMed ID: 10517502
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups.
Lauber C; Klink B; Seifert M
BMC Cancer; 2018 Apr; 18(1):399. PubMed ID: 29631562
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of human oligodendrogliomas with the help of the NeuroShell Easy Classifier neural network.
Iglesias J; Esparza J; Scherf M
Anal Quant Cytol Histol; 2000 Oct; 22(5):383-92. PubMed ID: 11064814
[TBL] [Abstract][Full Text] [Related]
17. Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas.
Zhu JJ; Santarius T; Wu X; Tsong J; Guha A; Wu JK; Hudson TJ; Black PM
Genes Chromosomes Cancer; 1998 Mar; 21(3):207-16. PubMed ID: 9523195
[TBL] [Abstract][Full Text] [Related]
18. The T2-FLAIR mismatch sign as an imaging biomarker for oligodendrogliomas in dogs.
Garcia-Mora J; Parker RL; Cecere T; Robertson JL; Rossmeisl JH
J Vet Intern Med; 2023; 37(4):1447-1454. PubMed ID: 37246729
[TBL] [Abstract][Full Text] [Related]
19. Conventional and advanced (DTI/SWI) neuroimaging findings in pediatric oligodendroglioma.
Wagner MW; Poretti A; Huisman TA; Bosemani T
Childs Nerv Syst; 2015 Jun; 31(6):885-91. PubMed ID: 25813856
[TBL] [Abstract][Full Text] [Related]
20. Materialities of mundane care and the art of holding one's own.
Brownlie J; Spandler H
Sociol Health Illn; 2018 Feb; 40(2):256-269. PubMed ID: 29464771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
